WO2016181195A1 - Improved process for water soluble iron carbohydrate complexes - Google Patents
Improved process for water soluble iron carbohydrate complexes Download PDFInfo
- Publication number
- WO2016181195A1 WO2016181195A1 PCT/IB2015/054655 IB2015054655W WO2016181195A1 WO 2016181195 A1 WO2016181195 A1 WO 2016181195A1 IB 2015054655 W IB2015054655 W IB 2015054655W WO 2016181195 A1 WO2016181195 A1 WO 2016181195A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- maltodextrin
- ferric
- oxidation
- solution
- complex
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 37
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims description 45
- 229910052742 iron Inorganic materials 0.000 title claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims description 20
- -1 iron carbohydrate Chemical class 0.000 title claims description 7
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 62
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 52
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 52
- MFBBZTDYOYZJGB-HAONTEFVSA-L (2s,3s,4s,5r)-4-[(2r,3r,4r,5s,6r)-5-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoate;iron(3+);oxyg Chemical compound O.[OH-].[O-2].[Fe+3].O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H](O)CO)[C@@H](O)[C@H](O)C([O-])=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 MFBBZTDYOYZJGB-HAONTEFVSA-L 0.000 claims abstract description 40
- 229960004131 ferric carboxymaltose Drugs 0.000 claims abstract description 40
- 229960004887 ferric hydroxide Drugs 0.000 claims abstract description 26
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 26
- 230000003647 oxidation Effects 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 23
- 239000003054 catalyst Substances 0.000 claims abstract description 16
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 claims abstract description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 81
- 239000000243 solution Substances 0.000 claims description 75
- MSNWSDPPULHLDL-UHFFFAOYSA-K ferric hydroxide Chemical compound [OH-].[OH-].[OH-].[Fe+3] MSNWSDPPULHLDL-UHFFFAOYSA-K 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical class [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 claims description 20
- 239000007864 aqueous solution Substances 0.000 claims description 19
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 18
- 229920002245 Dextrose equivalent Polymers 0.000 claims description 17
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 claims description 16
- 239000007800 oxidant agent Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 12
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 11
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims description 11
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 8
- 230000002378 acidificating effect Effects 0.000 claims description 6
- 229910052723 transition metal Inorganic materials 0.000 claims description 6
- 150000003624 transition metals Chemical class 0.000 claims description 6
- QYTDEUPAUMOIOP-UHFFFAOYSA-N TEMPO Chemical group CC1(C)CCCC(C)(C)N1[O] QYTDEUPAUMOIOP-UHFFFAOYSA-N 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 230000009918 complex formation Effects 0.000 abstract description 3
- 235000014413 iron hydroxide Nutrition 0.000 abstract description 3
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 abstract description 3
- 150000002978 peroxides Chemical class 0.000 abstract description 3
- IEECXTSVVFWGSE-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide Chemical compound [OH-].[O-2].[Fe+3] IEECXTSVVFWGSE-UHFFFAOYSA-M 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
- 239000011541 reaction mixture Substances 0.000 description 16
- 239000008213 purified water Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000012258 stirred mixture Substances 0.000 description 11
- 229910020341 Na2WO4.2H2O Inorganic materials 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 239000002002 slurry Substances 0.000 description 10
- WPZFLQRLSGVIAA-UHFFFAOYSA-N sodium tungstate dihydrate Chemical compound O.O.[Na+].[Na+].[O-][W]([O-])(=O)=O WPZFLQRLSGVIAA-UHFFFAOYSA-N 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 230000001376 precipitating effect Effects 0.000 description 9
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 238000001816 cooling Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 3
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- AYOOGWWGECJQPI-NSHDSACASA-N n-[(1s)-1-(5-fluoropyrimidin-2-yl)ethyl]-3-(3-propan-2-yloxy-1h-pyrazol-5-yl)imidazo[4,5-b]pyridin-5-amine Chemical compound N1C(OC(C)C)=CC(N2C3=NC(N[C@@H](C)C=4N=CC(F)=CN=4)=CC=C3N=C2)=N1 AYOOGWWGECJQPI-NSHDSACASA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- FWZTTZUKDVJDCM-CEJAUHOTSA-M disodium;(2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;iron(3+);oxygen(2-);hydroxide;trihydrate Chemical compound O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FWZTTZUKDVJDCM-CEJAUHOTSA-M 0.000 description 2
- MWSPFHZPVVWJCO-UHFFFAOYSA-M hydron;methyl(trioctyl)azanium;sulfate Chemical compound OS([O-])(=O)=O.CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC MWSPFHZPVVWJCO-UHFFFAOYSA-M 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 150000004698 iron complex Chemical group 0.000 description 2
- 229940032961 iron sucrose Drugs 0.000 description 2
- MVZXTUSAYBWAAM-UHFFFAOYSA-N iron;sulfuric acid Chemical compound [Fe].OS(O)(=O)=O MVZXTUSAYBWAAM-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- BIIBYWQGRFWQKM-JVVROLKMSA-N (2S)-N-[4-(cyclopropylamino)-3,4-dioxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-2-[[(E)-3-(2,4-dichlorophenyl)prop-2-enoyl]amino]-4,4-dimethylpentanamide Chemical compound CC(C)(C)C[C@@H](C(NC(C[C@H](CCN1)C1=O)C(C(NC1CC1)=O)=O)=O)NC(/C=C/C(C=CC(Cl)=C1)=C1Cl)=O BIIBYWQGRFWQKM-JVVROLKMSA-N 0.000 description 1
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- HFGHRUCCKVYFKL-UHFFFAOYSA-N 4-ethoxy-2-piperazin-1-yl-7-pyridin-4-yl-5h-pyrimido[5,4-b]indole Chemical compound C1=C2NC=3C(OCC)=NC(N4CCNCC4)=NC=3C2=CC=C1C1=CC=NC=C1 HFGHRUCCKVYFKL-UHFFFAOYSA-N 0.000 description 1
- QWMFKVNJIYNWII-UHFFFAOYSA-N 5-bromo-2-(2,5-dimethylpyrrol-1-yl)pyridine Chemical compound CC1=CC=C(C)N1C1=CC=C(Br)C=N1 QWMFKVNJIYNWII-UHFFFAOYSA-N 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000011021 bench scale process Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 150000002009 diols Chemical group 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- VOVZXURTCKPRDQ-CQSZACIVSA-N n-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide Chemical compound C1[C@H](O)CCN1C1=NC=C(C(=O)NC=2C=CC(OC(F)(F)Cl)=CC=2)C=C1C1=CC=NN1 VOVZXURTCKPRDQ-CQSZACIVSA-N 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- JXHZRQHZVYDRGX-UHFFFAOYSA-M sodium;hydrogen sulfate;hydrate Chemical compound [OH-].[Na+].OS(O)(=O)=O JXHZRQHZVYDRGX-UHFFFAOYSA-M 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
- C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
- C08B30/18—Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/18—Oxidised starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/04—Starch derivatives, e.g. crosslinked derivatives
- C08L3/10—Oxidised starch
Definitions
- the present invention provides an improved process for the preparation of water soluble trivalent iron carbohydrate complexes.
- the present invention provides an improved process for the preparation of Ferric carboxymaltose.
- Iron deficiency anaemia is a common haematological complication with potentially serious clinical consequences that may require intravenous iron therapy.
- Ferric carboxymaltose is a stable, non-dextran iron formulation administered intravenously in large single doses to treat IDA. It is an iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell. It is commercially available in the market under the trade name Ferinject®
- Ferric carboxymaltose has been designed to provide high iron utilisation and to have a better benefit to risk profile than iron dextran and iron sucrose therapy.
- iron dextran a key risk is the reaction with anti-dextran antibodies leading to the well known dextran induced anaphylactic reactions.
- iron sucrose the negative characteristics include high pH, high osmolarity, low dosage limits and the long duration of administration.
- Ferric carboxymaltose allows for controlled delivery of iron within the cells of the reticuloendothelial system and subsequent delivery to the iron-binding proteins ferritin and transferrin, with minimal risk of release of large amounts of ionic iron in the serum.
- the iron(III)-polymaltose complex compound preferably has a molecular weight in the range from 20,000 to 500,000 daltons, preferably from 30,000 to 80,000 daltons.
- U.S. Patent No. 7,612,109 discloses water-soluble iron carbohydrate complexes (ferric carboxymaltose complexes) obtainable from an aqueous solution of an iron (III) salt, preferably iron (III) chloride, and an aqueous solution of the oxidation product of one or more maltodextrins using an aqueous hypochlorite solution.
- iron (III) salt preferably iron (III) chloride
- PCT application No.WO2011/055374 discloses a process for the preparation of iron (III) carboxymaltose complex using ferric hydroxide.
- An object of the present invention is to provide an improved process for the preparation of iron carbohydrate complex having weight average molecular weight of 80 kDa to 400 kDa obtainable from oxidation of maltodextrins with peroxide and ferric hydroxide or iron hydroxide maltodextrin complex in the presence of sodium tungstate as a catalyst.
- Another object of the present invention is to provide an improved process for the preparation of Ferric carboxymaltose (FCM) obtainable from oxidation of maltodextrins with peroxide and ferric hydroxide or iron hydroxide maltodextrin complex in the presence of sodium tungstate as a catalyst.
- FCM Ferric carboxymaltose
- the present invention provides an improved process for the preparation of water soluble trivalent iron carbohydrate complex having a weight average molecular weight of 80kDa to 400 kDa obtainable from oxidation of maltodextrins using a non-hypohalite oxidising agent and ferric hydroxide or ferric hydroxide maltodextrin complex.
- the present invention provides an improved process for the preparation of Ferric carboxymaltose (FCM) which comprises reacting an aqueous solution of Iron (III) complex and aqueous solution of oxidised maltodextrin wherein the oxidation is carried out using a non-hypohalite oxidising agent.
- FCM Ferric carboxymaltose
- the present invention provides an improved process for the preparation of water soluble trivalent iron carbohydrate complex having a weight average molecular weight of 80kDa to 400 kDa obtainable from oxidation of maltodextrins using a non- hypohalite oxidising agent in the presence of sodium tungstate as a catalyst, at an acidic pH, and complex formation with ferric hydroxide or ferric hydroxide maltodextrin complex wherein, when one maltodextrin is present, the maltodextrin has a dextrose equivalent of between 5 and 20, and wherein, when a mixture of more than one maltodextrin is present, the dextrose equivalent of each individual maltodextrin is between 2 and 40, and the dextrose equivalent of the mixture is between 5 and 20.
- the present invention provides an improved process for the preparation of Ferric carboxymaltose (FCM) which comprises reacting an aqueous solution of Iron (III) complex and aqueous solution of oxidised maltodextrin wherein the oxidation is carried out using non-hypohalite oxidising agent selected from hydrogen peroxide, TEMPO (2,2,6, 6-Tetramethylpiperidinyloxy) or mixture thereof at an acidic pH in the presence of Starks catalyst (Methyl trioctyl ammonium hydrogen sulphate).
- FCM Ferric carboxymaltose
- the oxidation reaction is carried out in the presence of a catalyst such as transition metal catalyst, for example sodium tungstate.
- a catalyst such as transition metal catalyst, for example sodium tungstate.
- Sodium tungstate used in the present invention can be anhydrous, monohydrate, dihydrate or any other variation thereof.
- the amount of catalyst is kept as low as possible in order to achieve the end product which can easily be purified, and more specifically catalytic amounts are sufficient.
- Aqueous solution of Iron (III) complex of the present invention used as starting material is ferric hydroxide or polymeric ferric hydroxide maltodextrin complex.
- the process for the preparation of Ferric carboxymaltose (FCM) according to the present invention comprises:
- step (b) reacting the freshly prepared step- (a) ferric hydroxide with maltodextrin and non- hypohalite oxidising agent in the presence of catalyst to give Ferriccarboxymaltose.
- a freshly prepared ferric hydroxide is used in step-(b).
- the process for the preparation of Ferric carboxymaltose (FCM) according to the present invention comprises:
- the present invention provides an improved process for the preparation of Ferric carboxymaltose (FCM) which comprises:
- FCM Ferric carboxymaltose
- the obtained oxidized maltodextrins are reacted with ferric hydroxide.
- the oxidized maltodextrins can be isolated and re-dissolved.
- the obtained aqueous solutions of the oxidized maltodextrins directly for further reaction with ferric hydroxide.
- the aqueous solution of the oxidized maltodextrin can be mixed with ferric hydroxide in order to carry out the reaction.
- the oxidation may be carried out in an acidic solution, for example at a pH of 1 to 3.
- the oxidation may be carried out at temperatures in the range of 15 to 100°C, preferably of 50 to 90° C.
- the reaction may be carried out for a period of 10 minutes to 4 hours, e.g. 1 to 3 hours.
- the aqueous solution of the oxidized maltodextrin can be mixed with an aqueous solution of the iron (III) salt in order to carry out the reaction. It is preferred to proceed in a manner so that during and immediately after mixing of the oxidized maltodextrin and the iron (III) salt, the pH is moderately acidic and adjusted to an alkaline pH to a value in the range of 8 to 12, preferably 9to 11, and maintaining the reaction at a temperature of 25 to 60°C, preferably 50 to 55°C.
- the oxidation pH is initially maintained at 1 to 3 and at a temperature of 40 to 100°C, followed by adjusting the pH between 8 to 12 with an aqueous alkali hydroxide, preferably sodium hydroxide and maintaining the reaction at a temperature of 35 to 55 °C, preferably 50 to 55°C for iron complex formation. Later, the pH can be lowered to 5 to 6, preferably 5.5, by the addition of an acid and maintaining the reaction at a temperature of 35 to 125 °C, preferably 50 to 100°C. It is preferable to use inorganic or organic acids or a mixture thereof, specifically hydrohalic acids such as aqueous hydrochloric acid.
- Step (ii) 20grams of maltodextrin having a dextrose equivalents of 13-17 were dissolved in 50ml of purified water and the solution was metered in the course of 20 minutes to a stirred mixture of 2.66gm of Starks catalyst (methyl trioctyl ammonium hydrogen sulfate prepared in-situ from 2gm of Aliquat 336 and 0.66gm of NaHSO 4 .H 2 O), 0.8gm of sodium tungstate dihydrate and 0.37gm of TEMPO at RT. 31.12gm of hydrogen peroxide solution (50-55% w/v) was then added drop wise over a period of 40 minutes at 25-30°C and raised the temperature to90-95°C and stirred for 3 hours.
- Starks catalyst methyl trioctyl ammonium hydrogen sulfate prepared in-situ from 2gm of Aliquat 336 and 0.66gm of NaHSO 4 .H 2 O
- step (i) (ferric hydroxide maltodextrin complex) was added, with stirring. 14.0ml of 20% aqueous sodium hydroxide solution was added to adjust the reaction mass pH to 10- 10.5 and the slurry was heated to 50°C, stirred for 30 minutes. Then the reaction mixture was acidified to pH 5.5 by adding hydrochloric acid solution and the mixture was maintained at 50°C for another 30 minutes. Further temperature was raised to 95-100°C and stirred for 14 hours.
- step (i) from example- 1 was added and stirred for 10 minutes.
- 14ml of 20% NaOH solution was added to adjust the reaction mass pH to 10- 10.5 and the slurry was heated to 50°C, stirred for 30 minutes.
- the mixture was acidified to pH 5.5 by adding hydrochloric acid solution and the solution was maintained at 50°C for another 30 minutes. Further temperature was raised to 95-100°C and stirred for 13 hours.
- step (i) from example- 1 was added and stirred for 10 minutes.
- step (i) from example-6 was added and stirred for 10 minutes.
- a pH of 10-10.5 was established by adding 12ml of 20% NaOH solution and the slurry was heated to 50°C, stirred at this temperature for 30 minutes. Then the solution was acidified to pH 5.5 with hydrochloric acid addition and the solution was maintained at 50°C for another 30 minutes. Further temperature was raised to 95- 100°C and stirred for 12 hours.
- the reaction mixture was allowed to cool to 25-30°C, adjusted pH to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was isolated by precipitating with ethanol (315.0g) addition drop wise at room temperature. The obtained brown amorphous solid was dried in vacuum at 50°C for 2-3 hours.
- Molecular weight 340 kDa.
- Iron content 23.28 % w/w
- step (i) from example- 1 was added and stirred for 10 minutes.
- a pH of 10-10.5 was established by adding 12ml of 20% NaOH solution and the slurry was heated to 50°C, stirred at this temperature for 30 minutes. Then the solution was acidified to pH 5.5 with hydrochloric acid addition and the solution was maintained at 50°C for another 30 minutes. Further temperature was raised to 95- 100°C and stirred for 12 hours.
- the reaction mixture was allowed to cool to room temperature, adjusted pH to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was isolated by precipitating with ethanol (304.0g) addition drop wise at room temperature. The obtained brown amorphous solid was dried under vacuum at 50°C for 2-3 hours.
- Molecular weight 352 kDa.
- Iron content 23.0 % w/w
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
The present invention provides an improved process for the preparation of Ferric carboxymaltose (FCM) complex. In this process the oxidation of maltodextrins are carried out by using peroxide in the presence of sodium tungstate catalyst and later complex formation with ferric hydroxide or iron hydroxide maltodextrin complex.
Description
IMPROVED PROCESS FOR WATER SOLUBLE IRON
CARBOHYDRATE COMPLEXES
Field of the Invention
The present invention provides an improved process for the preparation of water soluble trivalent iron carbohydrate complexes. In particular, the present invention provides an improved process for the preparation of Ferric carboxymaltose.
Background of the Invention
Iron deficiency anaemia (IDA) is a common haematological complication with potentially serious clinical consequences that may require intravenous iron therapy.
Ferric carboxymaltose (FCM) is a stable, non-dextran iron formulation administered intravenously in large single doses to treat IDA. It is an iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell. It is commercially available in the market under the trade name Ferinject®
Ferric carboxymaltose has been designed to provide high iron utilisation and to have a better benefit to risk profile than iron dextran and iron sucrose therapy. In the case of iron dextran, a key risk is the reaction with anti-dextran antibodies leading to the well known dextran induced anaphylactic reactions. In the case of iron sucrose, the negative characteristics include high pH, high osmolarity, low dosage limits and the long duration of administration. Ferric carboxymaltose allows for controlled delivery of iron within the cells of the reticuloendothelial system and subsequent delivery to the iron-binding proteins ferritin and transferrin, with minimal risk of release of large amounts of ionic iron in the serum. U.S. Pat. No. 3,076,798 discloses a process for the preparation of iron(III)- polymaltose complex compounds. The iron(III)-polymaltose complex compound
preferably has a molecular weight in the range from 20,000 to 500,000 daltons, preferably from 30,000 to 80,000 daltons.
U.S. Patent No. 7,612,109 discloses water-soluble iron carbohydrate complexes (ferric carboxymaltose complexes) obtainable from an aqueous solution of an iron (III) salt, preferably iron (III) chloride, and an aqueous solution of the oxidation product of one or more maltodextrins using an aqueous hypochlorite solution.
PCT application No.WO2011/055374, discloses a process for the preparation of iron (III) carboxymaltose complex using ferric hydroxide.
In Netherlands article, starch 41 (1989) Nr .8, S. 303-309 transition metal ions enhance the selectivity of oxidations by H2O2 to produce polysaccharides to polydicarbonates by glycol cleavage of the C2-C3 vicinal diol moiety.
Even though many prior art processes reported methods for the preparation of Iron(III) carboxymaltose, each process has some limitations with respect to yield, purity and scale-up etc.
Objectives of the Invention An object of the present invention is to provide an improved process for the preparation of iron carbohydrate complex having weight average molecular weight of 80 kDa to 400 kDa obtainable from oxidation of maltodextrins with peroxide and ferric hydroxide or iron hydroxide maltodextrin complex in the presence of sodium tungstate as a catalyst.
Another object of the present invention is to provide an improved process for the preparation of Ferric carboxymaltose (FCM) obtainable from oxidation of maltodextrins with peroxide and ferric hydroxide or iron hydroxide maltodextrin complex in the presence of sodium tungstate as a catalyst.
Summary of the invention
Accordingly, the present invention provides an improved process for the preparation of water soluble trivalent iron carbohydrate complex having a weight average molecular weight of 80kDa to 400 kDa obtainable from oxidation of maltodextrins using a non-hypohalite oxidising agent and ferric hydroxide or ferric hydroxide maltodextrin complex.
In another aspect, the present invention provides an improved process for the preparation of Ferric carboxymaltose (FCM) which comprises reacting an aqueous solution of Iron (III) complex and aqueous solution of oxidised maltodextrin wherein the oxidation is carried out using a non-hypohalite oxidising agent.
Detailed description of the invention
The present invention provides an improved process for the preparation of water soluble trivalent iron carbohydrate complex having a weight average molecular weight of 80kDa to 400 kDa obtainable from oxidation of maltodextrins using a non- hypohalite oxidising agent in the presence of sodium tungstate as a catalyst, at an acidic pH, and complex formation with ferric hydroxide or ferric hydroxide maltodextrin complex wherein, when one maltodextrin is present, the maltodextrin has a dextrose equivalent of between 5 and 20, and wherein, when a mixture of more than one maltodextrin is present, the dextrose equivalent of each individual maltodextrin is between 2 and 40, and the dextrose equivalent of the mixture is between 5 and 20.
In another embodiment the present invention provides an improved process for the preparation of Ferric carboxymaltose (FCM) which comprises reacting an aqueous solution of Iron (III) complex and aqueous solution of oxidised maltodextrin wherein the oxidation is carried out using non-hypohalite oxidising agent selected from hydrogen peroxide, TEMPO (2,2,6, 6-Tetramethylpiperidinyloxy) or mixture thereof at an acidic pH in the presence of Starks catalyst (Methyl trioctyl ammonium hydrogen sulphate).
In yet another embodiment the present invention provides a process for the preparation of Ferric carboxymaltose (FCM) wherein the oxidation is carried out in the presence of transition metal catalyst. In yet another embodiment the oxidation reaction is carried out in the presence of a catalyst such as transition metal catalyst, for example sodium tungstate. Sodium tungstate used in the present invention can be anhydrous, monohydrate, dihydrate or any other variation thereof. Specifically, the amount of catalyst is kept as low as possible in order to achieve the end product which can easily be purified, and more specifically catalytic amounts are sufficient.
Aqueous solution of Iron (III) complex of the present invention used as starting material is ferric hydroxide or polymeric ferric hydroxide maltodextrin complex.
In a preferred embodiment, the process for the preparation of Ferric carboxymaltose (FCM) according to the present invention comprises:
a) treating ferric chloride with aqueous sodium hydroxide to prepare ferric hydroxide,
b) reacting the freshly prepared step- (a) ferric hydroxide with maltodextrin and non- hypohalite oxidising agent in the presence of catalyst to give Ferriccarboxymaltose.
Preferably, a freshly prepared ferric hydroxide is used in step-(b).
In yet another preferred embodiment, the process for the preparation of Ferric carboxymaltose (FCM) according to the present invention comprises:
a) treating ferric chloride with aqueous sodium hydroxide and maltodextrin to prepare ferric hydroxide maltodextrin complex,
b) reacting ferric hydroxide maltodextrin complex prepared in step- (a) with maltodextrin and non-hypohalite oxidising agent in the presence of catalyst to give Ferric carboxymaltose. In yet another preferred embodiment the present invention provides an improved process for the preparation of Ferric carboxymaltose (FCM) which comprises:
a) oxidizing at least one maltodextrin in an aqueous solution at a pH in the range of lto 3 and a temperature in the range of 15 to 100 °C, with hydrogen peroxide solution to form an oxidized maltodextrin solution,
b) contacting the oxidized maltodextrin solution with an aqueous solution of an iron (III) hydroxide complex and
c) raising the pH of the oxidized maltodextrin solution and iron (III) salt to a value in the range of 8 to 12
d) isolating Ferric carboxymaltose (FCM) by adding alcohol to the aqueous complex solution.
To prepare the complex of the invention, the obtained oxidized maltodextrins are reacted with ferric hydroxide. In order to do so, the oxidized maltodextrins can be isolated and re-dissolved. It is also possible to use the obtained aqueous solutions of the oxidized maltodextrins directly for further reaction with ferric hydroxide. For instance, the aqueous solution of the oxidized maltodextrin can be mixed with ferric hydroxide in order to carry out the reaction.
The oxidation may be carried out in an acidic solution, for example at a pH of 1 to 3. The oxidation may be carried out at temperatures in the range of 15 to 100°C, preferably of 50 to 90° C. The reaction may be carried out for a period of 10 minutes to 4 hours, e.g. 1 to 3 hours.
The aqueous solution of the oxidized maltodextrin can be mixed with an aqueous solution of the iron (III) salt in order to carry out the reaction. It is preferred to proceed in a manner so that during and immediately after mixing of the oxidized
maltodextrin and the iron (III) salt, the pH is moderately acidic and adjusted to an alkaline pH to a value in the range of 8 to 12, preferably 9to 11, and maintaining the reaction at a temperature of 25 to 60°C, preferably 50 to 55°C. During the oxidation pH is initially maintained at 1 to 3 and at a temperature of 40 to 100°C, followed by adjusting the pH between 8 to 12 with an aqueous alkali hydroxide, preferably sodium hydroxide and maintaining the reaction at a temperature of 35 to 55 °C, preferably 50 to 55°C for iron complex formation. Later, the pH can be lowered to 5 to 6, preferably 5.5, by the addition of an acid and maintaining the reaction at a temperature of 35 to 125 °C, preferably 50 to 100°C. It is preferable to use inorganic or organic acids or a mixture thereof, specifically hydrohalic acids such as aqueous hydrochloric acid.
The following examples describes the nature of the invention and are given only for the purpose of illustrating the present invention in more detail and are not limitative and relate to solutions which have been particularly effective on a bench scale.
EXAMPLES
Example- 1: Preparation of trivalent iron carboxymaltose
Step (i)
20grams of anhydrous iron(III)chloride was dissolved in 50ml of purified water at room temperature for 10 minutes stirring. To this 2gm of maltodextrin (13-17 dextrose equivalents) was added and stirred for 10 minutes at room temperature. The obtained brownish-yellow clear solution was cooled to 0-5°C and the pH of the reaction mixture was adjusted to 7.0 by adding 20% aqueous sodium hydroxide solution. A brown colour precipitate obtained was maintained for 1 hour at 0-5°C and collected through filtration (Wet cake wt. ~ 65. Og). The cake was suck dried and used for next step. Step (ii)
20grams of maltodextrin having a dextrose equivalents of 13-17 were dissolved in 50ml of purified water and the solution was metered in the course of 20 minutes to a stirred mixture of 2.66gm of Starks catalyst (methyl trioctyl ammonium hydrogen sulfate prepared in-situ from 2gm of Aliquat 336 and 0.66gm of NaHSO4.H2O), 0.8gm of sodium tungstate dihydrate and 0.37gm of TEMPO at RT. 31.12gm of hydrogen peroxide solution (50-55% w/v) was then added drop wise over a period of 40 minutes at 25-30°C and raised the temperature to90-95°C and stirred for 3 hours. After cooling to room temperature, a second portion of 15.5gm of H2O2 solution was metered in the course of 15 minutes at 25-30°C and the resulting solution was again refluxed at 90- 95°C for 1 hour. After cooling to 35-40°C, wet cake of step (i) (ferric hydroxide maltodextrin complex) was added, with stirring. 14.0ml of 20% aqueous sodium hydroxide solution was added to adjust the reaction mass pH to 10- 10.5 and the slurry was heated to 50°C, stirred for 30 minutes. Then the reaction mixture was acidified to pH 5.5 by adding hydrochloric acid solution and the mixture was maintained at 50°C for another 30 minutes. Further temperature was raised to 95-100°C and stirred for 14 hours. Then the reaction mixture was cooled to room temperature and filtered through a celite pad. Thereafter, the iron(III)complex was isolated by precipitation by adding ethanol (237. Og) drop wise at room temperature. The obtained brown amorphous solid was dried under vacuum at 50°C for 2-3 hours. Molecular weight = 202 kDa. Iron content = 23.38% w/w
Example-2:
20grams of maltodextrin (13-17 dextrose equivalents) were dissolved in 50ml of purified water and the solution was added to a stirred mixture of 2.66gm of Starks catalyst and 0.2gm of Na2WO4.2H2O at room temperature in the course of 20 minutes. 24grams of H2O2 solution was metered in the course of 45 minutes at 25-30°C and raised the temperature to 90-95°C and stirred for 2 hours and cooled to room temperature. The solution was added to another portion of a stirred mixture of 1.33gm of Starks catalyst and 0.2gm of Na2WO4.2H2O at room temperature. Thereafter, 12gm of
H2O2solution was added drop wise over a period of 20 minutes at 25-30°C and the resulting reaction mixture was again refluxed at 90-95°C for 2 hours. After cooling to 25-30°C, wet cake of step (i) from example- 1 was added and stirred for 10 minutes. 14ml of 20% NaOH solution was added to adjust the reaction mass pH to 10- 10.5 and the slurry was heated to 50°C, stirred for 30 minutes. Then the mixture was acidified to pH 5.5 by adding hydrochloric acid solution and the solution was maintained at 50°C for another 30 minutes. Further temperature was raised to 95-100°C and stirred for 13 hours. Then the reaction solution was cooled to room temperature, adjusted pH to 5.5 to 6.0 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was isolated by precipitating with ethanol (331.0g) addition drop wise at room temperature. The obtained brown amorphous solid was dried in vacuum at 50°C for 2-3 hours. Molecular weight = 200 kDa. Iron content = 25.57 % w/w
Example-3:
20grams of maltodextrin (13-17 dextrose equivalents) were dissolved in 100ml of purified water and the solution was added to a stirred mixture of 2.66gm of Starks catalyst, 0.8gm of Na2WO4.2H2O and 0.37gm of TEMPO at room temperature over a period of 15 minutes. 30grams of H2O2solution was added drop wise in the course of 1 hour at 25-30°C and raised the temperature to 90-95°C, stirred for 3 hours and cooled to room temperature.
At 25-30°C, wet cake of step (i) from example- 1 was added and stirred for 10 minutes. A pH of 10-10.5 was established by adding 12ml of 20% NaOH solution and the slurry was heated to 50°C, stirred at this temperature for 30 minutes. Then the reaction mixture was acidified to pH 5.5 with hydrochloric acid addition and the mixture was maintained at 50°C for another 30 minutes. Further temperature was raised to 95-100°C and stirred for 14 hours. The reaction mixture was allowed to cool to room temperature, adjusted pH to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was isolated by precipitating with ethanol (343.0g) addition drop wise at room temperature. The obtained brown
amorphous solid was dried in vacuum at 50°C for 2-3 hours. Molecular weight = 260 kDa. Iron content = 23.67 % w/w
Example-4:
20grams of maltodextrin (13-17 dextrose equivalents) were dissolved in 50ml of purified water and the solution was added to a stirred mixture of 2.66gm of Starks catalyst, 0.8gm of Na2WO4.2H2O and 0.37g of TEMPO at room temperature over a period of 15 minutes. 30grams of H2O2 solution was added drop wise over a period of 1 hour at 55-60°C and the temperature was raised to 90-95 °C, stirred for 3 hours and cooled to room temperature. After cooling to 25-30°C, wet cake of step (i) from example- 1 was added and stirred for 10 minutes. A pH of 10-10.5 was established by adding 12ml of 20% NaOH solution and the slurry was heated to 50°C, stirred at this temperature for 30 minutes. Then the reaction mixture was acidified to pH 5.5 with hydrochloric acid addition and was maintained at 50°C for another 30 minutes. Further temperature was raised to 95-100°C and stirred for 12 hours. The reaction mixture was allowed to cool to room temperature, adjusted pH to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was isolated by precipitating with ethanol (343.0g) addition drop wise at room temperature. The obtained brown amorphous solid was dried under vacuum at 50°C for 2-3 hours. Molecular weight = 261 kDa. Iron content = 22.85 % w/w
Example-5:
Step (i)
16grams of anhydrous iron(III)chloride was dissolved in 50ml of purified water at room temperature for 10 min stirring. The obtained brownish-yellow clear solution was cooled to 0-5°C and the pH was adjusted to 7.0 first by adding aqueous sodium carbonate solution (21gm of Na2CO3dissolved in 102 ml of purified water) and then by adding 20% NaOH solution. A brown colour precipitate obtained was maintained for 1 hour at 0-5°C and collected through filtration (Wet wt. ~54.0g). The cake was suck dried and used for next step.
Step (ii)
20grams of maltodextrin (13-17 dextrose equivalents) were dissolved in 50ml of purified water and the solution was added to a stirred mixture of 2.66gm of Starks catalyst, 0.8gm of Na2WO4.2H2O and 0.37gm of TEMPO at room temperature over a period of 15 minutes. 30gm of H2O2solution was added drop wise over a period of 1 hour at 25-30°C and the temperature was raised to 90-95°C, stirred for 3 hours and cooled to room temperature.
At 25-30°C, wet cake of step (i) added and stirred for 10 minutes. 20% NaOH solution was added drop wise to adjust the reaction mass pH tolO-10.5 and the slurry was heated to 50°C, stirred for 30 minutes. Then the solution was acidified to pH 5.5 with hydrochloric acid addition and the solution was kept at 50°C for another 30 minutes. Further temperature was raised to 95-100°C and stirred for 12 hours. The reaction mixture was allowed to cool to room temperature, adjusted pH to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was isolated by precipitating with ethanol (315.0g) addition drop wise at room temperature. The obtained brown amorphous solid was dried under vacuum at 50°C for 2-3 hours. Molecular weight = 236 kDa. Iron content = 22.35 % w/w Example-6:
Step (i)
20grams of anhydrous ferric chloride was dissolved in 50ml of purified water at room temperature for 10 min stirring. The obtained brownish-yellow clear solution was cooled to 0-5°C and the pH was adjusted to 7.0 by adding 20% NaOH solution. A brown colour precipitate obtained was stirred for 1 hour at 0-5°C and collected through filtration. The cake was suck dried and used for next step.
Step (ii)
20grams of maltodextrin (13-17 dextrose equivalents) were dissolved in 50ml of purified water and the solution was added to a stirred mixture of 2.66gm of Starks catalyst, 0.8gm of Na2WO4.2H2O and 0.37g of TEMPO at room temperature over a
period of 15 minutes. 36gm of H2O2 solution was metered in the course of 1 hour at 25-30°C and the resulting solution was heated to 90-95°C, stirred for 3 hours and cooled to room temperature. After cooling to 25-30°C, wet cake of step (i) was added and stirred for 10 min. 12ml of 20% NaOH solution was added drop wise to adjust the reaction mass pH to 10-10.5 and the slurry was heated to 50°C, kept at this temperature for 30 minutes. Then the solution was acidified to pH 5.5 with hydrochloric acid addition and the solution was maintained at 50°C for another 30 minutes. Further temperature was raised to 95- 100°C and stirred for 12 hours. The reaction mixture was allowed to cool to room temperature, adjusted pH to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was isolated by precipitating with ethanol (315.0g) addition at room temperature. The obtained brown amorphous solid was dried under vacuum at 50°C for 2-3 hours. Molecular weight = 365 kDa. Iron content = 23.93 % w/w
Example-7:
20grams of maltodextrin (13-17 dextrose equivalents) were dissolved in 50ml of purified water and the solution was added to a stirred mixture of 2.66gm of Starks catalyst, 0.2gm of Na2WO4.2H2O and 0.37gm of TEMPO at room temperature over a period of 15 minutes. 30gm of H2O2 solution was added drop wise in the course of 1 hour at 25-30°C and the temperature was raised to 90-95°C, stirred for 3 hours and cooled to room temperature. At 25-30°C, wet cake of step (i) from example-6 was added and stirred for 10 minutes. A pH of 10-10.5 was established by adding 12.0ml of 20% NaOH solution and the slurry was heated to 50°C, stirred at this temperature for 30 minutes. Then the solution was acidified to pH 5.5 with hydrochloric acid addition and the solution was kept at 50°C for another 30 minutes. Further temperature was raised to 95-100°C and stirred for 12 hours. The reaction mixture was allowed to cool to room temperature; pH was adjusted to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite
pad. Then the iron(III)complex was isolated by precipitating with ethanol (276.0g) addition drop wise at room temperature. The obtained brown amorphous solid was dried in vacuum at 50°C for 2-3 hours. Molecular weight = 366 kDa. Iron content = 21.2 % w/w
Example-8:
20grams of maltodextrin (13-17 dextrose equivalents) were dissolved in 50ml of purified water and the solution was added to a stirred mixture of 2.66gm of Starks catalyst and 0.8gm of Na2WO4.2H2O at room temperature over a period of 15 minutes. 30grams of H2O2 solution was metered in the course of 1 hour at 25-30°C and the temperature was raised to 90-95°C, stirred for 3 hours and cooled to room temperature.
At 25-30°C, wet cake of step (i) from example-6 was added and stirred for 10 minutes. A pH of 10-10.5 was established by adding 12ml of 20% NaOH solution and the slurry was heated to 50°C, stirred at this temperature for 30 minutes. Then the solution was acidified to pH 5.5 with hydrochloric acid addition and the solution was maintained at 50°C for another 30 minutes. Further temperature was raised to 95- 100°C and stirred for 12 hours. The reaction mixture was allowed to cool to 25-30°C, adjusted pH to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was isolated by precipitating with ethanol (315.0g) addition drop wise at room temperature. The obtained brown amorphous solid was dried in vacuum at 50°C for 2-3 hours. Molecular weight = 340 kDa. Iron content = 23.28 % w/w
Example-9:
20grams of maltodextrin (13-17 dextrose equivalents) were dissolved in 50ml of purified water and the solution was added to a stirred mixture of 2.66gm of Starks catalyst, 0.8gm of Na2WO4.2H2O and 0.37gm of TEMPO at room temperature over a period of 15 minutes. 30grams of H2O2 solution was added drop wise over a period of
1 hour at 25-30°C and the resulting solution was heated to 90-95°C, stirred for 3 hours and cooled to room temperature.
At 25-30°C, wet cake of step (i) from example- 1 was added and stirred for 10 minutes. A pH of 10-10.5 was established by adding 12ml of 20% NaOH solution and the slurry was heated to 50°C, stirred at this temperature for 30 minutes. Then the solution was acidified to pH 5.5 with hydrochloric acid addition and the solution was maintained at 50°C for another 30 minutes. Further temperature was raised to 95- 100°C and stirred for 12 hours. The reaction mixture was allowed to cool to room temperature, adjusted pH to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was isolated by precipitating with ethanol (304.0g) addition drop wise at room temperature. The obtained brown amorphous solid was dried under vacuum at 50°C for 2-3 hours. Molecular weight = 352 kDa. Iron content = 23.0 % w/w
Example-10:
20grams of maltodextrin (13-17 dextrose equivalents) were dissolved in 50ml of purified water and the solution was added to a stirred mixture of 2.66gm of Starks catalyst, 0.8gm of Na2WO4.2H2O and 0.37gm of TEMPO at room temperature over a period of 15 minutes. 30grams of H2O2 solution was added drop wise in the course of 60 minutes at 25-30°C and the temperature was raised to 90-95°C, stirred for 3 hours and cooled to room temperature.
At 25-30°C, wet cake of step (i) from example- 1 was added and stirred for 10 minutes. 12ml of 20% NaOH solution was added drop wise to adjust the reaction mixture pH to 10-10.5 and the temperature of the slurry was raised to 50°C, stirred at this temperature for 30 minutes. Then the reaction mixture was acidified to pH 5.5 with hydrochloric acid addition and was maintained at 50°C for another 30 minutes. Further temperature was raised to 95-100°C and stirred for 12 hours. The reaction mixture was allowed to cool to room temperature, adjusted pH to 6.0 to 6.5 with 20% NaOH solution and filtered through a celite pad. Then the iron(III)complex was
isolated by precipitating with ethanol (276.0g) addition drop wise at room temperature. The obtained brown amorphous solid was dried in vacuum at 50°C for 2- 3 hours. Molecular weight = 348 kDa. Iron content = 24.6 % w/w
Claims
1. An improved process for the preparation of water soluble trivalent iron carbohydrate complex having a weight average molecular weight of 80 kDa to 400 kDa obtainable from oxidation of maltodextrins using a non-hypohalite oxidising agent and ferric hydroxide or ferric hydroxide maltodextrin complex.
2. The process as claimed in claim 1, for the preparation of Ferric carboxymaltose (FCM) which comprises reacting an aqueous solution of Ferric (III) complex and aqueous solution of oxidised maltodextrin wherein the oxidation is carried out using a non-hypohalite oxidising agent.
3. The process as claimed in claim 1, for the preparation of Ferric carboxymaltose (FCM) which comprises reacting an aqueous solution of ferric hydroxide and aqueous solution of oxidised maltodextrin wherein the oxidation is carried out using a non- hypohalite oxidising agent.
4. The process as claimed in claims 1 to 3, wherein when one maltodextrin is present, the maltodextrin has a dextrose equivalent of between 5 and 20, and wherein, when a mixture of more than one maltodextrin is present, the dextrose equivalent of each individual maltodextrin is between 2 and 40, and the dextrose equivalent of the mixture is between 5 and 20.
5. The process as claimed in claims 1 to 3, wherein non-hypohalite oxidising agent is selected from hydrogen peroxide, TEMPO (2,2,6,6- Tetramethylpiperidinyloxy) or mixture thereof.
6. The process as claimed in claims 1 to 3, wherein the oxidation is wherein oxidation is carried out using non-hypohalite oxidising agent at an acidic pH in the presence of Starks catalyst.
7. The process as claimed in claims 1 to 3, wherein the oxidation is carried out at a pH of 1 to 3, at temperatures in the range of 15 to 100 °C.
8. The process as claimed in claims 1 to 3, wherein the oxidation is carried out in the presence of transition metal catalyst.
9. The process as claimed in claim 8, wherein the oxidation is carried out in the presence of transition metal catalyst is sodium tungstate.
10. An improved for the preparation of Ferric carboxymaltose (FCM) which comprises:
a) treating ferric chloride with aqueous sodium hydroxide to prepare ferric hydroxide, b) reacting the freshly prepared ferric hydroxide of step-(a) with maltodextrin and non-hypohalite oxidising agent in the presence of catalyst to give Ferric carboxymaltose.
11. An improved process for the preparation of Ferric carboxymaltose (FCM) which comprises:
a) treating ferric chloride with aqueous sodium hydroxide and maltodextrin to prepare ferric hydroxide maltodextrin complex,
b) reacting ferric hydroxide maltodextrin complex prepared in step-(a) with maltodextrin and non-hypohalite oxidising agent in the presence of catalyst to give Ferric carboxymaltose.
12. An improved process for the preparation of Ferric carboxymaltose (FCM) which comprises:
a) oxidizing at least one maltodextrin in an aqueous solution at a pH in the range of 1 to 3 and a temperature in the range of 15 to 100 °C, with hydrogen peroxide solution to form an oxidized maltodextrin solution,
b) contacting the oxidized maltodextrin solution with an aqueous solution of an iron (III) hydroxide complex and
c) raising the pH of the oxidized maltodextrin solution and iron (III) salt to a value in the range of 8 to 12
d) isolating Ferric earboxymaltose (FCM) by adding alcohol to the aqueous complex solution.
13. The process as claimed in claims 10 to 12, wherein non-hypohalite oxidising agent is selected from hydrogen peroxide, TEMPO (2,2,6,6- Tetramethylpiperidinyloxy) or mixture thereof.
14. The process as claimed in claims 10 to 12, wherein the oxidation is carried out using non-hypohalite oxidising agent at an acidic pH in the presence of Starks catalyst.
15. The process as claimed in claims 10 to 12, wherein the oxidation is carried out using non-hypohalite oxidising agent at an acidic pH in the presence of Starks catalyst.
16. The process as claimed in claims 10 to 12, wherein the oxidation is carried out in the presence of transition metal catalyst.
17. The process as claimed in claim 16, wherein the oxidation is carried out in the presence of transition metal catalyst is sodium tungstate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2360CH2015 | 2015-05-08 | ||
IN2360/CHE/2015 | 2015-05-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016181195A1 true WO2016181195A1 (en) | 2016-11-17 |
Family
ID=55521745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2015/054655 WO2016181195A1 (en) | 2015-05-08 | 2015-06-20 | Improved process for water soluble iron carbohydrate complexes |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2016181195A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3339329A1 (en) | 2016-12-22 | 2018-06-27 | LEK Pharmaceuticals d.d. | Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes |
CN111050802A (en) * | 2017-09-11 | 2020-04-21 | 法码科思莫斯控股有限公司 | Iron complex compounds for therapeutic use |
US11123321B2 (en) | 2002-10-23 | 2021-09-21 | Vifor (International) Ag | Aqueous iron carbohydrate complexes, their production and medicaments containing them |
US11406656B2 (en) | 2006-01-06 | 2022-08-09 | American Regent, Inc. | Methods and compositions for administration of iron |
US11447513B2 (en) * | 2020-02-12 | 2022-09-20 | Rk Pharma Inc. | Purification process of ferric carboxymaltose |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3076798A (en) | 1961-02-23 | 1963-02-05 | Hausmann Lab Ltd | Process for preparing a ferric hydroxide polymaltose complex |
WO2004037865A1 (en) * | 2002-10-23 | 2004-05-06 | Vifor (International) Ag | Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
WO2011055374A2 (en) | 2009-11-04 | 2011-05-12 | Symed Labs Limited | Process for the preparation of iron (iii) carboxymaltose complex |
-
2015
- 2015-06-20 WO PCT/IB2015/054655 patent/WO2016181195A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3076798A (en) | 1961-02-23 | 1963-02-05 | Hausmann Lab Ltd | Process for preparing a ferric hydroxide polymaltose complex |
WO2004037865A1 (en) * | 2002-10-23 | 2004-05-06 | Vifor (International) Ag | Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
US7612109B2 (en) | 2002-10-23 | 2009-11-03 | Vifor (International) Ag | Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
WO2011055374A2 (en) | 2009-11-04 | 2011-05-12 | Symed Labs Limited | Process for the preparation of iron (iii) carboxymaltose complex |
Non-Patent Citations (4)
Title |
---|
FLOOR M ET AL: "OXIDATION OF MALTODEXTRINS AND STARCH BY THE SYSTEM TUNGSTATE-HYDROGEN PEROXIDE", STARCH: INTERNATIONAL JOURNAL FOR THE INVESTIGATION, PROCESSING AND USE OF CARBOHYDRATES AND THEIR DERIVATIVES, WILEY-VCH VERLAG, WEINHEIM, DE, vol. 41, no. 8, 1 August 1989 (1989-08-01), pages 303 - 309, XP000045510, ISSN: 0038-9056 * |
NETHERLANDS ARTICLE, no. 8, 1989, pages 303 - 309 |
THABURET J F ET AL: "TEMPO-mediated oxidation of maltodextrins and d-glucose: effect of pH on the selectivity and sequestering ability of the resulting polycarboxylates", CARBOHYDRATE RESEARCH, PERGAMON, GB, vol. 330, no. 1, 10 January 2001 (2001-01-10), pages 21 - 29, XP027210778, ISSN: 0008-6215, [retrieved on 20010110] * |
VARELA O: "OXIDATIVE REACTIONS AND DEGRADATIONS OF SUGARS AND POLYSACCHARIDES", ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 58, 1 January 2003 (2003-01-01), pages 307 - 369, XP008027949, DOI: 10.1016/S0065-2318(03)58006-4 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11123321B2 (en) | 2002-10-23 | 2021-09-21 | Vifor (International) Ag | Aqueous iron carbohydrate complexes, their production and medicaments containing them |
US11590097B2 (en) | 2002-10-23 | 2023-02-28 | Vifor (International) Ag | Aqueous iron carbohydrate complexes, their production and medicaments containing them |
US11406656B2 (en) | 2006-01-06 | 2022-08-09 | American Regent, Inc. | Methods and compositions for administration of iron |
US11433091B2 (en) | 2006-01-06 | 2022-09-06 | American Regent, Inc. | Methods and compositions for administration of iron |
US11478502B2 (en) | 2006-01-06 | 2022-10-25 | American Regent, Inc. | Methods and compositions for administration of iron |
EP3339329A1 (en) | 2016-12-22 | 2018-06-27 | LEK Pharmaceuticals d.d. | Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes |
CN111050802A (en) * | 2017-09-11 | 2020-04-21 | 法码科思莫斯控股有限公司 | Iron complex compounds for therapeutic use |
US11447513B2 (en) * | 2020-02-12 | 2022-09-20 | Rk Pharma Inc. | Purification process of ferric carboxymaltose |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180105609A1 (en) | Preparation of water soluble trivalent iron carbohydrate complexes | |
WO2016181195A1 (en) | Improved process for water soluble iron carbohydrate complexes | |
NZ539243A (en) | Water-soluble iron-carbohydrate complexes, their production and medicaments containing them | |
US20120214986A1 (en) | Process for the preparation of iron (iii) carboxymaltose complex | |
CN110105469A (en) | The easypro more glucose sodium impurity and preparation method thereof of one kind | |
EP3339329A1 (en) | Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes | |
KR101617884B1 (en) | Process for the preparation of platinum acetylacetonato complexes | |
US7005531B2 (en) | Method of making iron(III)gluconate complex | |
CN102875463B (en) | Synthesis method for high-quality and low-cost bispyrithione | |
JPH11322722A (en) | Method for producing potassium oxonate | |
CN108659082A (en) | A kind of preparation method for treating grice diarrhoea scutelloside Zn complex | |
JPS60156673A (en) | Manufacture of quinolic acid from quinoline | |
HUT56336A (en) | Continuous industrial process for producing aqueous solution of glyoxylic acid | |
CN108047276B (en) | A kind of method of synthesizing ruthenium (III) acetylacetonate | |
CN113698448A (en) | Preparation method of amcinonide | |
CN111689881B (en) | Synthetic method of azosemide intermediate | |
CN104726504B (en) | Laccase catalytic synthesis method of 5, 5' -dehydro-divanillyl acetone | |
CN115368478B (en) | Preparation method of ferric carboxymaltose | |
JPH03271275A (en) | Production of quinolinic acid | |
CN112320999B (en) | Method for recovering rhodium in rhodium-containing wastewater | |
CN107129466A (en) | The synthetic method of the picoline N oxides of 4 chlorine, 3 methoxyl group 2 | |
JP4864247B2 (en) | Selective production method of p-iodophenol | |
JPH03157371A (en) | Production of quinolinic acid | |
PT97935A (en) | PROCESS OF TRANSFORMATION OF N-OXIDES OF TERTIARY ANIMALS IN ALDEES AND PREPARATION OF INSATURATED ALDEIDS | |
CN117126309A (en) | Preparation method of sodium sugammadex intermediate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15841044 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15841044 Country of ref document: EP Kind code of ref document: A1 |